Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenic mechanisms and therapeutic implications of extracellular matrix remodelling in cerebral vasospasm. | Fluids Barriers CNS | 2023 | 37925414 | PubTator, text mining | PubMed |
| Epigenetics insights from perceived facial aging. | Clin Epigenetics | 2023 | 37924108 | PubTator, text mining | PubMed |
| Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience. | Can J Kidney Health Dis | 2023 | 37920777 | PubTator, text mining | PubMed |
| Novel roles for cooperating collagen receptor families in fibrotic niches. | Curr Opin Cell Biol | 2023 | 37918273 | PubTator, text mining | PubMed |
| Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells. | Stem Cell Res Ther | 2023 | 37907977 | PubTator, text mining | PubMed |
| Cell-Tissue Interaction: The Biomimetic Approach to Design Tissue Engineered Biomaterials. | Bioengineering (Basel) | 2023 | 37892852 | PubTator, text mining | PubMed |
| NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology. | NPJ Precis Oncol | 2023 | 37884744 | PubTator, text mining | PubMed |
| Structure of LRRK1 and mechanisms of autoinhibition and activation. | Nat Struct Mol Biol | 2023 | 37857821 | PubTator, text mining | PubMed |
| The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature. | Front Immunol | 2023 | 37854588 | PubTator, text mining | PubMed |
| Mechanobiology of portal hypertension. | JHEP Rep | 2023 | 37841641 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | 37834454 | PubTator, text mining | PubMed |
| Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions. | Int J Mol Sci | 2023 | 37834343 | PubTator, text mining | PubMed |
| Single-Cell Profiling of Cells in the Lung of a Patient with Chronic Hypersensitivity Pneumonitis Reveals Inflammatory Niche with Abundant CD39+ T Cells with Functional ATPase Phenotype: A Case Study. | Int J Mol Sci | 2023 | 37833889 | PubTator, text mining | PubMed |
| Endothelial discoidin domain receptor 1 senses flow to modulate YAP activation. | Nat Commun | 2023 | 37833282 | PubTator, text mining | PubMed |
| Brazilian Society of Otology task force - Vestibular Schwannoma ‒ evaluation and treatment. | Braz J Otorhinolaryngol | 2023 | 37813009 | PubTator, text mining | PubMed |
| Investigating the conformational landscape of AlphaFold2-predicted protein kinase structures. | Bioinform Adv | 2023 | 37786533 | PubTator, text mining | PubMed |
| M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. | Arthritis Res Ther | 2023 | 37784134 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study. | Clin Orthop Relat Res | 2023 | 37768856 | PubTator, text mining | PubMed |
| Advantages of photo-curable collagen-based cell-laden bioinks compared to methacrylated gelatin (GelMA) in digital light processing (DLP) and extrusion bioprinting. | Mater Today Bio | 2023 | 37766893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=14